AMD Commits 128 Billion to Taiwan Chip Ecosystem Challenging Nvidias Dominance SpaceXs Potential SP Sector Classification Rockets Satellites AI and Data Centers Hanois Fine Dining Scene Highlights Seven Restaurants at the Forefront of Culinary Innovation Trump Administration Maintains Iran Naval Blockade Until Agreement Reached President Dismisses Critics Leerink Revises Price Target on BeOne Medicines Market Implications for ONC Keeping Up Appearances The Hidden Costs of Financial Secrecy in Relationships Evolution Petroleum EPM Q1 2026 Earnings Steep Earnings Miss Sends Stock Lower AES Q1 2026 Earnings EPS Surges 80 Above Estimates Powered by Strong Execution SHF Holdings Inc SHFS Q3 2024 Earnings Modest Profitability Amid Cannabis Financial Services Landscape BOC Q4 2025 Earnings Deep Loss Misses Estimate Despite Stock Rebound ENR Q1 2026 Earnings EPS Surges Past Estimates by Over 100 Precipio Inc PRPO Q2 2025 Earnings Unexpected Profitability Amid Revenue Challenges Stardust Power SDST Gains 5 as Shares Test Key Resistance Levels Geospace Technologies GEOS Slides to 810 Navigating Support and Resistance Levels Adams Natural Resources Fund PEO Holds Steady Near Support as Energy Sector Stabilizes NovoCure NVCR Holds Steady With Modest Gains Testing Key Levels Profound Medical PROF Hovers Near Support Amid Modest Decline Portfolio Manager Trims HighFlying Stock After 80 Surge Since April Initiation Kestrel Group Ltd Q3 2024 Earnings Net Loss Reported Amid Broader Market Headwinds Rapport Therapeutics RAPP Holds Steady as Minor Decline Tests Key Support Levels Contrarian Signal Emerges as Market Timers Rush for Exits Retirement Age Rising Many Older Workers Cannot Afford to Quit Fed Faces Tighter Path to Rate Cuts as Jobs Data Highlights Persistent Inflation Concerns Kevin Warsh Set to Assume Federal Reserve Chairmanship on Friday Vestas Wind Systems Shares Decline as Company Warns Margins May Hit Guidance Low End Kevin Warsh Returns to Fed Amid Internal Debate Over Interest Rate Cuts Traders Bet on IonQ Micron Anduril as Next US Government Stake Targets